Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin

Conditions

• Dyslipidemia With Hypertension

Interventions

• DRUG: Group I (Telmisartan 80 mg, Amlodipine 10 mg, Rosuvastatin 20 mg)
• DRUG: Group II (Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo)
• DRUG: Group III (Telmisartan 80 mg, Amlodipine placebo, Rosuvastatin 20 mg)

Sponsor

Jeil Pharmaceutical Co., Ltd.